G
Giuseppe Celano
Researcher at University of Bari
Publications - 28
Citations - 1417
Giuseppe Celano is an academic researcher from University of Bari. The author has contributed to research in topics: Lactobacillus plantarum & Gut flora. The author has an hindex of 12, co-authored 28 publications receiving 643 citations.
Papers
More filters
Journal ArticleDOI
The Controversial Role of Human Gut Lachnospiraceae.
Mirco Vacca,Giuseppe Celano,Francesco Maria Calabrese,Piero Portincasa,Marco Gobbetti,Maria De Angelis +5 more
TL;DR: Changes in Lachnospiraceae abundances according to health and disease are discussed and how nutrients from the host diet can influence their growth and how their metabolites can, in turn, influence host physiology are analyzed.
Journal ArticleDOI
House microbiotas as sources of lactic acid bacteria and yeasts in traditional Italian sourdoughs.
TL;DR: The results of this study suggest that the dominant species of sourdough LAB and yeasts dominated also the house microbiota.
Journal ArticleDOI
Lactic Acid Bacteria in Durum Wheat Flour Are Endophytic Components of the Plant during Its Entire Life Cycle.
Fabio Minervini,Giuseppe Celano,Anna Lattanzi,Luigi Tedone,Giuseppe De Mastro,Marco Gobbetti,Maria De Angelis +6 more
TL;DR: Assessment of the dynamics of lactic acid bacteria and other Firmicutes associated with durum wheat organs and processed products showed that Lactobacillus, Streptococcus, Enteritiscus, and Lactococcus were the main epiphytic and endophytic genera among lactic Acid bacteria.
Journal ArticleDOI
Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients.
Girolamo Ranieri,Michele Ammendola,Rosa Patruno,Giuseppe Celano,Francesco Alfredo Zito,Severino Montemurro,Addolorata Rella,Valentina Di Lecce,Cosmo Damiano Gadaleta,Giovanni Battista De Sarro,Domenico Ribatti +10 more
TL;DR: The results suggest that tryptase-positive MCs play a role in breast cancer angiogenesis, and several tryPTase inhibitors such as gabexate mesilate and nafamostat mesilates might be evaluated in clinical trials as a new anti-angiogenetic approach.
Journal ArticleDOI
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk.
Agostino Di Ciaula,Jacek Baj,Gabriella Garruti,Giuseppe Celano,Maria De Angelis,Helen H. Wang,Domenica Maria Di Palo,Leonilde Bonfrate,David Q.-H. Wang,Piero Portincasa +9 more
TL;DR: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide and parallels comorbidities such as obesity, metabolic syndrome, dyslipidemia, and diabetes, with mechanisms partially independent from excessive caloric intake.